Cargando…
Reply to Nyman, U.; Aspelin, P. Regarding Iodixanol for Pediatric CTA. Comment on “Pop, M. Cardiothoracic CTA in Infants Referred for Aortic Arch Evaluation—Retrospective Comparison of Iomeprol 350, Ioversol 350, Iopromide 370 and Iodixanol 320. Children 2021, 8, 949”
Autor principal: | Pop, Marian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9140064/ https://www.ncbi.nlm.nih.gov/pubmed/35626886 http://dx.doi.org/10.3390/children9050709 |
Ejemplares similares
-
Cardiothoracic CTA in Infants Referred for Aortic Arch Evaluation—Retrospective Comparison of Iomeprol 350, Ioversol 350, Iopromide 370 and Iodixanol 320
por: Pop, Marian
Publicado: (2021) -
Regarding Iodixanol for Pediatric CTA. Comment on Pop, M. Cardiothoracic CTA in Infants Referred for Aortic Arch Evaluation—Retrospective Comparison of Iomeprol 350, Ioversol 350, Iopromide 370 and Iodixanol 320. Children 2021, 8, 949
por: Nyman, Ulf, et al.
Publicado: (2022) -
Comparison of Allergic Adverse Effects and Contrast Enhancement Between Iodixanol and Iopromide
por: Gharekhanloo, Farideh, et al.
Publicado: (2012) -
Iodixanol versus iopromide in patients with renal insufficiency undergoing coronary angiography with or without PCI
por: Zhang, Junyi, et al.
Publicado: (2018) -
Iopromide and Iodixanol in the Development of Postoperative Contrast Nephropathy in Patients with Renal Insufficiency: A Meta-Analysis
por: Feng, Yiyu, et al.
Publicado: (2022)